Fang Mei

Fang Mei

Auto-generated profile, based on publicly available information

Fang Mei

Department of Integrative Biology & Pharmacology, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, Texas

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 January 2020 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
WLWei Liu
Wei Liu
YHYonju Ha
Yonju Ha
FXFan Xia
Fan Xia
SZShuang Zhu
Shuang Zhu
YLYi Li
Yi Li
WZWenbo Zhang
Wenbo Zhang
Progressive loss of retinal ganglion cells (RGCs) leads to irreversible visual deficits in glaucoma. Here, we found that the level of cyclic AMP and the activity and expression of its mediator Epac1 were increased in retinas of two mouse models of ocular hypertension. Genetic depletion of Epac1 significantly attenuated ocular hypertension–induced detrimental effects in the retina, including vascular inflammation, neuronal apoptosis and necroptosis, thinning of ganglion cell complex layer, RGC loss, and retinal neuronal dysfunction. With bone marrow transplantation and various Epac1 conditional knockout mice, we further demonstrated that Epac1 in retinal neuronal cells (especially RGCs) was responsible for their death. Consistently, pharmacologic inhibition of Epac activity prevented RGC loss. Moreover, in vitro study on primary RGCs showed that Epac1 activation was sufficient to induce RGC death, which was mechanistically mediated by CaMKII activation. Taken together, these findings indicate that neuronal Epac1 plays a critical role in retinal neurodegeneration and suggest that Epac1 could be considered a target for neuroprotection in glaucoma.

3 January 2020 in Science Advances
Verified
Journal Article
Open access
PDF file
HLHua Liu
Hua Liu
FMFang C. Mei
Fang C. Mei
WYWenli Yang
Wenli Yang
HWHui Wang
Hui Wang
EWEitan Wong
Eitan Wong
XCXiaodong Cheng
Xiaodong Cheng
Epac1 promotes pathological blood vessel formation and is a therapeutic target for vasoproliferative diseases.

3 May 2023 in Pharmacological Reviews
Verified
Journal Article
Open access
PDF file
XCXiaodong Cheng
Xiaodong Cheng
WYWenli Yang
Wenli Yang
WLWei Lin
Wei Lin
FMFang Mei
Fang Mei
Protein SUMOylation is a major post-translational modification important for maintaining cellular homeostasis. SUMOylation has long been associated with stress responses as a diverse array of cellular stress signals are known to trigger rapid alternations in global protein SUMOylation. In addition, while there are large families of ubiquitination enzymes, all SUMOs are conjugated by a set of enzymatic machinery comprising one heterodimeric SUMO-activating enzyme, a single SUMO-conjugating enzyme, and a small number of SUMO protein ligases and SUMO-specific proteases. How a few SUMOylation enzymes specifically modify thousands of functional targets in response to diverse cellular stresses remains an enigma. Here, we review recent progress toward understanding the mechanisms of SUMO regulation, particularly, the potential roles of liquid-liquid phase separation/biomolecular condensates in the regulation of cellular SUMOylation during cellular stresses. In addition, we discuss the role of protein SUMOylation in pathogenesis and the development of novel therapeutics targeting SUMOylation. Significance Statement Protein SUMOylation is one of the most prevalent post-translational modifications and plays an important role in maintaining cellular homeostasis in response to stresses. Protein SUMOylation has been implicated in human pathogenesis such as cancer, cardiovascular diseases, neurodegeneration, and infection. After more than a quarter century of extensive research, intriguing enigmas remain regarding the mechanism of cellular SUMOylation regulation and the therapeutic potential of targeting SUMOylation.

22 April 2022 in Science Advances
Verified
Journal Article
Open access
WYWenli Yang
Wenli Yang
WRWilliam G. Robichaux
William G. Robichaux
FMFang C. Mei
Fang C. Mei
WLWei Lin
Wei Lin
LLLi Li
Li Li
XCXiaodong Cheng
Xiaodong Cheng
Protein SUMOylation plays an essential role in maintaining cellular homeostasis when cells are under stress. However, precisely how SUMOylation is regulated, and a molecular mechanism linking cellular stress to SUMOylation, remains elusive. Here, we report that cAMP, a major stress-response second messenger, acts through Epac1 as a regulator of cellular SUMOylation. The Epac1-associated proteome is highly enriched with components of the SUMOylation pathway. Activation of Epac1 by intracellular cAMP triggers phase separation and the formation of nuclear condensates containing Epac1 and general components of the SUMOylation machinery to promote cellular SUMOylation. Furthermore, genetic knockout of Epac1 obliterates oxidized low-density lipoprotein–induced cellular SUMOylation in macrophages, leading to suppression of foam cell formation. These results provide a direct nexus connecting two major cellular stress responses to define a molecular mechanism in which cAMP regulates the dynamics of cellular condensates to modulate protein SUMOylation.


1 February 2007 in Key Engineering Materials
Verified
Journal Article
Closed access
PDF file
MXM. M. Xu
M. M. Xu
FMFang Mei
Fang Mei
DLDan Li
Dan Li
XYXiao Yang
Xiao Yang
GSGang Sui
Gang Sui
XHX. Y. Hu
X. Y. Hu
Efficacy of poly(L-lactic acid) (PLLA)/nano-hydroxyapatite(HA) hybrid nanofibrous scaffolds for dental tissue engineering is described and their performance on normal cells with MG-63 is compared as well in this study. Perfectly PLLA/HA fibrous scaffolds were fabricated by an electrospinning process under optimal condition. Cell culcure and adenovirus encoding green fluorenscent protein technique were used to study the morphology of cells grown on the scaffolds. The results show that the growth of DPSCs and PCs is well observed attached to the PLLA/HA fibers, as well as MG-63, which indicate that the nanofibrous PLLA/HA scaffold could be used as a potential cell carrier in dental tissue engineering.